SinoHealth Tech (02361) has posted its interim financial results for the six months ended June 30, 2026, with net profit attributable to shareholders declining sharply by 89.29% to RMB 2.649 million.

During the reporting period, the group achieved revenue of RMB 162 million, representing a year-on-year increase of 9.19%. Basic earnings per share stood at RMB 0.01.

According to the company's announcement, revenue grew by 9.2% compared to the same period last year. Notably, revenue from AI applications reached RMB 16.8 million, marking a substantial surge of 295.0% year-on-year. This growth was primarily driven by incremental revenue from embedding AI capabilities into existing products such as Kaisi and Linghe, as well as the commercial monetization of intelligent agents. AI capabilities have begun to translate into tangible business revenue.